Research study Program year 2023 Source: CMS Open Payments

P1101ethu

Research payments

$235,946

35 payments

Through program year 2023, $235,946 in research payments was reported against P1101ethu, across 35 payments, paid by PharmaEssentia USA Corporation.

Paid by: PharmaEssentia USA Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2023	Research	$235,946	35

Breakdown

Who paid Research payments · program year 2023

PharmaEssentia USA Corporation $235,946 35 payments

Who received the money Research payments · program year 2023

Ut Md Anderson Cancer Center Teaching hospital · TX $70,350 2 payments
Montefiore Medical Center Organisation paid for research $44,309 14 payments
U Of Utah Neuropsychiatric Institute Teaching hospital · UT $34,887 6 payments
University Of Virginia Medical Cente Teaching hospital · VA $28,600 3 payments
Tulane University Medical Center Organisation paid for research $28,500 3 payments
Astera HealthCare Organisation paid for research $15,100 4 payments
Cancer Care Specialists Organisation paid for research $13,900 2 payments
Marin Cancer Care Organisation paid for research $300 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.